Jill Blumhoff, VP, Finance & CFO at BIOANALYTICAL SYSTEMS INC (BASI), bought 500 shares at $1.98 ($990) on 2019-06-11, disclosed to the SEC on 2019-06-13.
Open-market purchase of $990 BASI by VP, Finance & CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.